Plantar heel pain / plantar fasciopathy · Randomized trial · 2025
How does radial shockwave compare with physiotherapy and ultrasound for heel pain?
In this trial, heel pain fell from about 9 to about 3.5 out of 10 over six months with six sessions of radial shockwave, one a week. People who had 12 physiotherapy sessions with ultrasound improved by about the same amount.
Both helped- adults with heel pain
- 129
- sessions, one a week
- 6
- months of follow-up
- 6
Good to know: Run at a rehabilitation department in Tunisia. The 12-month follow-up was still under way.
Ines L, Rihab M, Sana B, et al. BMC Musculoskeletal Disorders, 2025 · Read the paper ↗
How this study worked
What happened
Heel pain
0–10 pain scale · start, then 1, 3 and 6 months after treatment
ShockwavePhysio + ultrasound
Show the numbers
| Group | Start | 1 month | 3 months | 6 months |
|---|---|---|---|---|
| Shockwave | 9.04 | 4.9 | 4.33 | 3.56 |
| Physio + ultrasound | 9.4 | 4.7 | 4.5 | 3.42 |
The treatment
Shockwave
Radial, once a week for 6 weeks
- Sessions
- 6, one a week
- Pulses
- 2,000 per session
- Strength
- 2.5bar · 10 per second
- Numbing
- Not mentioned
- Device
- BTL-6000
Compared with: 12 physiotherapy sessions over 4 weeks: stretching, deep massage and ultrasound
Settings are what each study used, not a prescription.
Who took part
129 adults aged 18 to 70 with heel pain for more than three months, at a rehabilitation department in Tunisia.
Side effects
The report did not list side effects.
All the numbers and the full appraisal
The results, in numbers.
Adults aged 18–70 with plantar fasciitis symptoms lasting over three months and baseline activity VAS ≥5, randomized to radial ESWT or physiotherapy plus ultrasound at a Tunisian rehabilitation department. The article reports 129 randomized (66 and 63); 4 lacked baropodometric data.
129 total randomized; baropodometric table reports 65 participants. VAS and success outcome denominators are not fully clear in the article.
129 total randomized; baropodometric table reports 60 participants. VAS and success outcome denominators are not fully clear in the article.
Pain intensity (VAS)4 reported outcomes
Pain intensity (VAS)
Visual Analogue Scale (0–10 cm, source-defined) VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT | — | 9.04 (SD 0.95) | 5.53 (SD 1.34) |
| Physiotherapy plus ultrasound | — | 9.4 (SD 0.75) | 5.57 (SD 1.25) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
ESWT versus physiotherapy plus ultrasound at the end of treatment; no significant between-group difference.
Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)
The stored group values are the end-of-treatment means; the 1-, 3- and 6-month means are stored as separate outcomes. Table 3 means (SD): baseline 9.04 (0.95) vs 9.4 (0.75), p=0.013; end treatment 5.53 (1.34) vs 5.57 (1.25), p=0.858; 1 month 4.9 (1.57) vs 4.7 (1.6), p=0.525; 3 months 4.33 (2.00) vs 4.5 (1.99), p=0.479; 6 months 3.56 (2.48) vs 3.42 (2.21), p=0.751. The source says no significant between-group difference after treatment; baseline pain differed.
Analysis details and source
No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.
Pain intensity (VAS)
Visual Analogue Scale (0–10 cm, source-defined) VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT | — | 9.04 (SD 0.95) | 4.9 (SD 1.57) |
| Physiotherapy plus ultrasound | — | 9.4 (SD 0.75) | 4.7 (SD 1.6) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
ESWT versus physiotherapy plus ultrasound one month after treatment; no significant between-group difference.
Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)
Table 3 means (SD) one month after treatment: 4.9 (1.57) with ESWT vs 4.7 (1.6) with physiotherapy plus ultrasound, p=0.525. Both groups improved from baseline (intragroup p<0.05, Table 3 footnote); baseline pain differed (9.04 vs 9.4, p=0.013).
Analysis details and source
No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.
Pain intensity (VAS)
Visual Analogue Scale (0–10 cm, source-defined) VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT | — | 9.04 (SD 0.95) | 4.33 (SD 2) |
| Physiotherapy plus ultrasound | — | 9.4 (SD 0.75) | 4.5 (SD 1.99) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
ESWT versus physiotherapy plus ultrasound three months after treatment; no significant between-group difference.
Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)
Table 3 means (SD) three months after treatment: 4.33 (2.00) with ESWT vs 4.5 (1.99) with physiotherapy plus ultrasound, p=0.479. Both groups improved from baseline (intragroup p<0.05, Table 3 footnote); baseline pain differed (9.04 vs 9.4, p=0.013).
Analysis details and source
No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.
Pain intensity (VAS)
Visual Analogue Scale (0–10 cm, source-defined) VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT | — | 9.04 (SD 0.95) | 3.56 (SD 2.48) |
| Physiotherapy plus ultrasound | — | 9.4 (SD 0.75) | 3.42 (SD 2.21) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
ESWT versus physiotherapy plus ultrasound six months after treatment; no significant between-group difference.
Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)
Table 3 means (SD) six months after treatment: 3.56 (2.48) with ESWT vs 3.42 (2.21) with physiotherapy plus ultrasound, p=0.751. Both groups improved from baseline (intragroup p<0.05, Table 3 footnote); baseline pain differed (9.04 vs 9.4, p=0.013).
Analysis details and source
No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.
Treatment success at 3 months (RMS)1 reported outcome
Treatment success at 3 months (RMS)
Roles and Maudsley score; success defined as good/excellent responder reported responders and percent
Table 4 shows excellent/good counts of 22/29 in ESWT and 20/23 in physiotherapy; the prose reports success rates as 54% versus 46% and p=0.250. The denominators/percentages are internally unclear, and another section defines success using alternative VAS criteria. Preserve the reported values as conflicting source statements; do not derive a rate.
Analysis details and source
Source reporting is internally inconsistent; no rate was reconstructed.
Recurrence by 6 months1 reported outcome
Recurrence by 6 months
Recurrence defined as VAS >5 after success at 3 months participants; proportion not reported by group
The report states 30 total recurrences (23.3%) and no significant difference between groups (p=0.06). Group counts and denominators are not supplied in the narrative.
Analysis details and source
No group-specific effect can be estimated from the presented information.
Baropodometric plantar-pressure measures1 reported outcome
Baropodometric plantar-pressure measures
Static baropodometry g/cm², cm² and percent as reported
Four participants lacked data; Table 2 lists n=65 ESWT and n=60 physiotherapy. Most measures did not differ between groups; left heel contact area did (54.2 (13.2) vs 48.5 (8.0) cm², p=0.005). Pain was correlated with plantar contact measures in the authors’ analysis. These baseline/association findings are not treatment effects.
Analysis details and source
Baseline comparison; multiple body-side measures and incomplete data.
Harms1 reported outcome
Harms
Adverse-event reporting events
The article does not describe a systematic adverse-event summary in its Results. This is unreported in the accessible article text, not evidence of zero events.
Analysis details and source
Harms were not adequately extractable; no event count inferred.
How treatment was delivered
BTL-6000 radial device; 2,000 pulses at 10 Hz and 2.5 bar; six sessions once weekly.
Twelve physiotherapy sessions over four weeks, three times weekly, combining plantar stretching, deep transverse massage and ultrasound.
VAS at baseline, immediately post-treatment and 1, 3, 6 and 12 months; blinded physician assessor. Roles and Maudsley score (RMS) at baseline, 3 and 12 months. Twelve-month follow-up was still ongoing in the report.
This report does not provide extractable systematic adverse-event counts. Do not interpret lack of a harms table as proof that no events occurred.
VAS starts with a statistically significant baseline difference between groups, while follow-up comparisons are reported without a between-group effect estimate or confidence interval.
The success-rate narrative and Table 4 do not align cleanly; the article also presents more than one success definition.
The 12-month follow-up was still ongoing, despite a planned long-term assessment.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- VAS starts with a statistically significant baseline difference between groups, while follow-up comparisons are reported without a between-group effect estimate or confidence interval.
- The success-rate narrative and Table 4 do not align cleanly; the article also presents more than one success definition.
- The 12-month follow-up was still ongoing, despite a planned long-term assessment.
Source-linked critical reading
Randomized comparative clinical trial
Technical source record
Complete article XML read, including methods, results, tables, figure captions, discussion, conclusion and disclosures.
Both groups’ pain scores improved in the short to medium term, with no clear difference reported after treatment. The study’s success counts are unclear, and it does not provide a clear harms summary.
Among adults with chronic plantar fasciitis, how did radial ESWT compare with physiotherapy plus ultrasound for pain and reported treatment success?
Two-arm randomized controlled study at one Tunisian hospital. The article reports 129 participants randomized (66 ESWT, 63 physiotherapy); four lacked baropodometric data. Follow-up at 12 months was still ongoing in the report.
Adults aged 18–70 with proximal plantar-fascia pain lasting over three months, tenderness and activity VAS ≥5. The report gives substantial baseline clinical characteristics, including an average symptom duration near 11 months.
Radial BTL-6000: 2,000 pulses, 10 Hz, 2.5 bar, six weekly sessions. Comparator received 12 sessions over four weeks of plantar stretching, deep transverse massage and ultrasound three times weekly. These are different treatment packages.
Active physiotherapy plus ultrasound, not sham. The study is open-label because treatments are recognizable, although pain assessment was by an assessor described as blinded.
VAS was assessed at baseline, end of treatment, 1, 3 and 6 months; 12-month follow-up was ongoing. Roles and Maudsley score was assessed at baseline and 3/12 months. Baropodometry was a secondary measure. The article’s success definitions are inconsistent.
At 3 months, VAS means were 4.33 (SD 2.00) versus 4.5 (1.99), p=0.479; at 6 months 3.56 (2.48) versus 3.42 (2.21), p=0.751. No between-group effect estimate or interval is supplied. Baseline VAS differed (p=0.013). Success rates are reported as 54% vs 46% in prose, while table counts do not clearly support those percentages; no reconstruction is appropriate.
The Results do not supply a clear systematic harms summary. This reporting gap cannot be interpreted as no adverse events.
Open-label treatment, baseline imbalances, unclear outcome denominators and conflicting success definitions limit inference. Follow-up was incomplete at 12 months. Baropodometric findings had four missing cases and are not treatment outcomes.
The comparison concerns two multi-component care packages in adults with chronic plantar heel pain. It does not establish equivalence, prove one package superior, or isolate the effect of shock waves from the treatment context.
Future reports should prespecify one success definition, provide arm-specific denominators and adjusted between-group estimates with intervals, complete longer follow-up and systematically report adverse events.
Read the original article.
The effectiveness of radial extracorporeal shock wave therapy (rESWT) in plantar fasciitis: a 12 months randomised controlled trial in a Tunisian rehabilitation department.
Ines L, Rihab M, Sana B, Saoussen L, Mariem G, Sinene F, Sonia J. · BMC musculoskeletal disorders · 2025
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →